References
- Bäckhed F., Manchester J.K., Semenkovich C.F., Gordon J.L.: Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. 104, 979–984 (2007)
- Boutagy N.E., McMillan R.P., Frisard M.I., Hulver M.W.: Metabolic endotoxemia with obesity: is it real and is it relevant? Biochimie, 124, 11–20 (2016)
- Brun P., Castagliuolo I., Di Leo V., Buda A., Pinzani M., Palù G., Martines D.: Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292, 518–525 (2007)
- Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., Burcelin R.: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 57, 1470–1481 (2008)
- Cani P.D., Burcelin R. i wsp.: Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56, 1761–1772 (2007)
- Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M.: Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia, 50, 2374–2383 (2007)
- Caricilli A., Castoldi A., Câmara N.: Intestinal barrier: A gentlemen’s agreement between microbiota and immunity. World J. Gastrointest. Pathophysiol. 5, 18–32 (2014)
- Działo J., Niedźwiedzka-Rystwej P., Mękal A., Deptuła W.: Charakterystyka tkanki limfatycznej błon śluzowych przewodu pokarmowego i układu oddechowego. Alergia Astma Immunologia, 15, 197–202 (2010)
- Fasano A.: Gut permeability, obesity, and metabolic disorders: who is the chicken and who is the egg ? Am. J. Clin. Nutr. 105, 3–4 (2017)
- Fasano A.: Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 91, 151–175 (2011)
- Fleissner C.K., Huebel N., Abd El-Bary M.M., Loh G., Klaus S., Blaut M.: Absence of intestinal microbiota does not protect mice from diet induced obesity. Br. J. Nutr. 104, 919–929 (2010)
- Flint H.J., Duncan S.H., Scott K.P., Louis P.: Interactions and competition within the microbial community of the human colon: links between diet and health. Environ. Microbiol. 9, 1101–1111 (2007)
- Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E.: Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50, 90–97 (2009)
- Kallio K.E., Hätönen K.A., Lehto M., Salomaa V., Männistö S., Pussinen P.J.: Endotoxemia, nutrition, and cardiometabolic disorders. Acta Diabetol. 52, 395–404 (2015)
- Kawashima H.: Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer. Biol. Pharm. Bull. 35, 1637–1641 (2012)
- Kłosiewicz-Latoszek L.: Otyłość jako problem społeczny, zdrowotny i leczniczy. Probl. Hig. Epidemiol. 91, 339–343 (2010)
- Kojima T., Murata M., Go M., Spray D., Sawada N.: Connexins induce and maintain tight junctions in epithelial cells. J. Membr. Biol. 217, 13–19 (2007)
- Lassenius M.I., Lehto M. I wsp.: Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care, 34, 1809–1815 (2011)
- Lee S.H.: Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest. Res. 13, 11–18 (2015)
- Lu Y.C., Yeh W.C., Ohashi P.S.: Lps/tlr4 signal transduction pathway. Cytokine, 42, 145–151 (2008)
- Mörkl S., Holasek S.J. i wsp.: Gut microbiota, dietary intakes and intestinal permeability reflected by serum zonulin in women. Eur. J. Nutr. 57, 2985–2997 (2018)
- Mowat A.: Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3, 331–341 (2003)
- Pendyala S., Walker J.M., Holt P.R.: A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology, 142, 1100–1101 (2012)
- Raetz C.R., Whitfield C.: Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635–700 (2002)
- Tilg H., Moschen A.R., Kaser B.: Obesity and the microbiota. Gastroenterology, 136, 1476–1483 (2009)
- Tokarz-Deptuła B., Śliwa-Dominiak J., Adamiak M., Bąk K., Deptuła W.: Bakterie komensalne a odporność układu pokarmowego, oddechowego i moczowo-płciowego. Post. Hig. Med. Dośw. 70, 599–609 (2016)
- Turnbaugh P.J., Bäckhed F., Fulton L., Gordon J.L.: Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe, 3, 213–223 (2008)
- Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I.: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444, 1027–1031 (2006)
- Umeda K., Matsui T., Nakayama M., Furuse K., Sasaki H., Furuse M., Tsukita S.: Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J. Biol. Chem. 279, 44785–44794 (2004)
- Van der Sluis M., Einerhand A.W. i wsp.: Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology, 131, 117–129 (2006)
- Wachowicz B., Saluk-Juszczak J.: Aktywność prozapalna lipopolisacharydu. Post. Bioch. 51, 280–287 (2005)
- Węgrzyn D., Adamek K., Łoniewska B.: Structure of the intestinal barrier. Pomeranian J. Life Sci. 63, 6–9 (2017)
- World Health Organization: Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (10.04.2019)
- Żak-Gołąb A., Kocełak P., Aptekorz M., Zientara M., Juszczyk L., Martirosian G., Chudek J., Olszanecka-Glinianowicz M.: Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int. J. Endocrinol. 2013, 674106 (2013)